Genetic control of retrovirus susceptibility in mammalian cells

Annual Review of Genetics

Volumn 38, Issue , 2004, Pages 61-85

  Goff, Stephen P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Early stages; Infection; Integration; Restriction; Reverse transcription

Indexed keywords

CYCLOPHILIN A; CYCLOSPORIN A; DNA BINDING PROTEIN; GAG PROTEIN; GENE PRODUCT; IMPORTIN 7; KARYOPHERIN; LENS EPITHELIUM DERIVED GROWTH FACTOR; REDOX EFFECTOR FACTOR 1; RETROVIRUS VECTOR; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIVIRAL ACTIVITY; APOBEC3G GENE; BINDING SITE; COMPLEX FORMATION; DNA LIBRARY; DNA PACKAGING; DNA SYNTHESIS; DRUG PROTEIN BINDING; DRUG TARGETING; ESCHERICHIA COLI; FV1 GENE; GENE; GENE ACTIVITY; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE INSERTION; GENE LOCUS; GENE REPLICATION; GENETIC SUSCEPTIBILITY; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFECTION SENSITIVITY; MOLECULAR CLONING; MULTIGENE FAMILY; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETROVIRUS; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; REVIEW; RNA STRUCTURE; RNA TRANSCRIPTION; VIF GENE; VIRION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS VIRULENCE;

ANIMALS; CARRIER PROTEINS; CELL LINE; CYCLOPHILIN A; DNA, COMPLEMENTARY; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; GENES; HIV-1; HUMANS; MACACA MULATTA; MICE; NUCLEOSIDE DEAMINASES; PROTEINS; REPRESSOR PROTEINS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; VIRUS REPLICATION;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INSERTION SEQUENCES; MAMMALIA; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 10944272588     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.38.072902.094136     Document Type: Review

References (141)

1. Alin K, Goff SP. 1996. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection. Virology 222:339-51
2. Bassin RH, Duran-Troise G, Berwin BI, Rein A. 1978. Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or gamma irradiation. J. Virol. 26:306-15
3. Bassin RH, Gerwin BI, Levin JG, Duran-Troise G, Benjers BM, Rein A. 1980. Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses. J. Virol. 35:287-97
4. Bates P, Young JA, Varmus HE. 1993. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 74:1043-51
5. Berger EA, Murphy PM, Farber JM. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700
6. Besnier C, Takeuchi Y, Towers G. 2002. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA 99:11920-25
7. Besnier C, Ylinen L, Strange B, Lister A, Takeuchi Y, et al. 2003. Characterization of murine leukemia virus restriction in mammals. J. Virol. 77:13403-6
8. Best S, Le Tissier P, Towers G, Stoye JP. 1996. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382:826-29
9. Bieniasz PD. 2003. Restriction factors: a defense against retroviral infection. Trends Microbiol. 11:286-91
10. Bishop KN, Bock M, Towers G, Stoye JP. 2001. Identification of the regions of Fv1 necessary for murine leukemia virus restriction. J. Virol. 75:5182-88
11. Boone LR, Glover PL, Innes CL, Niver LA, Bondurant MC, Yang WK. 1988. Fv-1 N- and B-tropism-specific sequences in murine leukemia virus and related endogenous proviral genomes. J. Virol. 62:2644-50
12. Boone LR, Innes CL, Heitman CK. 1990. Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line. J. Virol. 64:3376-81
13. Boone LR, Myer FE, Yang DM, Ou C-Y, Koh CK, et al. 1983. Reversal of Fv-1 host range by in vitro restriction endonuclease fragment exchange between molecular clones of N-tropic and B-tropic murine leukemia virus genomes. J Virol. 48:110-19
14. Borden KL. 2002. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell Biol. 22:5259-69
15. Braaten D, Ansari H, Luban J. 1997. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 71:2107-13
16. Braaten D, Franke EK, Luban J. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:3551-60
17. Braaten D, Luban J. 2001. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 20:1300-9
18. Brown PO. 1997. Integration. In Retroviruses, ed. JM Coffin, SH Hughes, HE Varmus, pp. 161-203. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
19. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, et al. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89:6580-84
20. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90:6125-29
21. Bushman FD. 1999. Host proteins in retroviral cDNA integration. Adv. Virus Res. 52:301-17
22. Bushman FD. 2003. Targeting survival: integration site selection by retroviruses and LTR-retrotransposons. Cell 115:135-38
23. Cairns TM, Craven RC. 2001. Viral DNA synthesis defects in assembly-competent rous sarcoma virus CA mutants. J. Virol. 75:242-50
24. Carrington M, Dean M, Martin MP, O'Brien SJ. 1999. Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. Hum. Mol. Genet. 8:1939-45
25. Casella CR, Raffini LJ, Panganiban AT. 1997. Pleiotropic mutations in the FHV-1 matrix protein that affect diverse steps in replication. Virology 228:294-306
26. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H. 1998. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72:1043-51
27. Chen H, Engelman A. 1998. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad Sci. USA 95:15270-74
28. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, et al. 2003. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 278:372-81
29. Cohen N, Sharma M, Kentsis A, Perez JM, Strudwick S, Borden KL. 2001. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. EMBO J. 20:4547-59
30. Cordonnier A, Casella J-F, Heidmann T 1995. Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J. Virol. 69:5890-97
31. Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, Bieniasz PD. 2002. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA 99:11914-19
32. Craven RC, Leure-duPree AE, Weldon RA Jr, Wills JW. 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69:4213-27
33. Crawford S, Goff SP. 1984. Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J. Virol. 49:909-17
34. Cullen BR. 2001. Journey to the center of the cell. Cell 105(6):697-700
35. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-84
36. DesGroseillers L, Jolicoeur P. 1983. Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48:685-96
37. Dorfman T, Gottlinger HG. 1996. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70:5751-57
38. Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, et al. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:196-207
39. Duran-Troise G, Bassin RH, Rein A, Gerwin BI. 1977. Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell 10:479-88
40. Duran-Troise G, Bassin RH, Wallace BF, Rein A. 1981. Balb/3T3 cells chronically infected with N-tropic murine leukemia virus continue to express Fv-1b restriction. Virology 112:795-99
41. Farnet CM, Bushman FD. 1997. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88:483-92
42. Farnet CM, Haseltine WA. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-15
43. Fassati A, Goff SP. 1999. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J. Virol. 73:8919-25
44. Fassati A, Goff SP. 2001. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75:3626-35
45. Fassati A, Gorlich D, Harrison I, Zaytseva L, Mingot JM. 2003. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J. 22:3675-85
46. Fouchier RA, Malim MH. 1999. Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv. Virus Res. 52:275-99
47. Fouchier RA, Simon JH, Jaffe AB, Malim MH. 1996. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 70:8263-69
48. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, et al. 1996. Crystal structure of human cyclophilin A bound to the ammo-terminal domain of HIV-1 capsid. Cell 87:1285-94
49. Gao G, Goff SP. 1999. Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection. Mol. Biol. Cell 10:1705-17
50. Gao K, Gorelick RJ, Johnson DG, Bushman F. 2003. Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro. J. Virol. 77:1598-603
51. Gardner M, Dandekar S, Cardiff R. 1986. Molecular mechanism of an ecotropic MuLV restriction gene Akvr-1/Fv-4 in California wild mice. Curr. Topics Microbiol. Immunol. 127:338-45
52. Gautsch JW, Elder JH, Schindler J, Jensen FC, Lerner RA. 1978. Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. Proc. Natl. Acad. Sci. USA 75:4170-74
53. Gilboa E, Mitra SW, Goff S, Baltimore D. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100
54. Goff SP. 1996. Operating under a Gag order: a block against incoming virus by the Fv1 gene. Cell 86:691-93
55. Goff SP. 2001. Retroviridae: the retroviruses and their replication. In Fields Virology, ed. DM Knipe, PM Howley, pp. 1871-939. Philadelphia: Lippincott Williams & Wilkins
56. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-9
57. Harris RS, Sheehy AM, Craig HM, Malim MH, Neuberger MS. 2003. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat. Immunol. 4:641-43
58. Hartley JW, Rowe WP, Huebner RJ. 1970. Host range restrictions of murine leukemia viruses in mouse embryo cell cultures. J. Virol. 5:221-25
59. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD, Towers GJ. 2003. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J. 22:385-94
60. Himathongkham S, Luciw PA. 1996. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219:485-8
61. Hindmarsh P, Ridky T, Reeves R, Andrake M, Skalka AM, Leis J. 1999. HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J. Virol. 73:2994-3003
62. Hofmann W, Schubert D, LaBonte J, Munson L, Gibson S, et al. 1999. Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73:10020-28
63. Hopkins N, Schindler J, Hynes R. 1977. Six NB-tropic murine leukemia viruses derived from a B-tropic virus of BALB/c have altered p30. J. Virol. 21:309-18
64. Hsu HW, Schwartzberg P, Goff SP. 1985. Point mutations in the P30 domain of the gag gene of Moloney murine leukemia virus. Virology 142:211-14
65. Jolicoeur P. 1979. The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr. Top. Microbiol. Immunol. 86:67-122
66. Jolicoeur P, Baltimore D. 1976. Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. Proc. Natl. Acad. Sci. USA 73:2236-40
67. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. 1994. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266:2002-6
68. Kashmiri SVS, Rein A, Bassin RH, Gerwin BI, Gisselbrecht S. 1977. Donation of N- or B-tropic phenotype to NB-tropic murine leukemia virus during mixed infections. J. Virol. 22:626-33
69. Katen LJ, Januszeski MM, Anderson WF, Hasenkrug KJ, Evans LH. 2001. Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. J. Virol. 75:5018-26
70. Kiernan RE, Ono A, Englund G, Freed EO. 1998. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72:4116-26
71. Kim W, Tang Y, Okada Y, Torrey TA, Chattopadhyay SK, et al. 1998. Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. J. Virol. 72:6898-901
72. Kizhatil K, Albritton LM. 1997. Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J. Virol. 71:7145-56
73. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM. 2003. Abrogation of post-entry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. USA 100:1298-303
74. Kozak CA, Chakraborti A. 1996. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology 225:300-5
75. Lecossier D, Bouchonnet F, Clavel F, Hance AJ. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112
76. Lee MS, Craigie R. 1994. Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proc. Natl. Acad. Sci. USA 91:9823-27
77. Lee MS, Craigie R. 1998. A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci. USA 95:1528-33
78. Lewis P, Hensel M, Emerman M. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:3053-58
79. Lewis PF, Emerman M. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-16
80. Li L, Farnet CM, Anderson WF, Bushman FD. 1998. Modulation of activity of Moloney murine leukemia virus preintegration complexes by host factors in vitro. J. Virol. 72:2125-31
81. Li L, Yoder K, Hansen MS, Olvera J, Miller MD, Bushman FD. 2000. Retroviral cDNA integration: stimulation by HMG I family proteins. J. Virol. 74:10965-74
82. Lilly F, Pincus T. 1973. Genetic control of murine viral leukemogenesis. Adv. Cancer Res. 17:231-77
83. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-78
84. Madani N, Kabat D. 1998. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72:10251-55
85. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, et al. 2003. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 278:33528-39
86. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103
87. Mariani R, Chen D, Schrofelbauer B, Navarro F, Koenig R, et al. 2003. Species-specific exclusion of AOPBEC3G from HIV-1 virions by Vif. Cell 114:21-31
88. Marin M, Rose KM, Kozak SL, Kabat D. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:1398-403
89. McClure MO, Sommerfelt MA, Marsh M, Weiss RA. 1990. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71(Part 4):767-73
90. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, et al. 2002. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159:441-52
91. Melchior F, Schergaut M, Pichler A. 2003. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 28:612-18
92. Miller DG, Adam MA, Miller AD. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-42
93. Miller MD, Farnet CM, Bushman FD. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:5382-90
94. Munk C, Brandt SM, Lucero G, Landau NR. 2002. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. USA 99:13843-48
95. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-67
96. Overbaugh J, Miller AD, Eiden MV. 2001. Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol. Mol. Biol. Rev. 65:371-89
97. Owens CM, Yang PC, Gottlinger H, Sodroski J. 2003. Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J. Virol. 77:726-31
98. Pincus T, Hartley JW, Rowe WP. 1971. A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occuring viruses. J. Exp. Med. 133:1219-33
99. Pincus T, Hartley JW, Rowe WP. 1975. A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1 sensitive and resistant cell cultures. Virology 65:333-42
100. Pryciak PM, Varmus HE. 1992. Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J. Virol. 66:5959-66
101. Rassa JC, Ross SR. 2003. Viruses and Toll-like receptors. Microbes Infect. 5:961-68
102. Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, Goff SP. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:642-50
103. Rein A, Kashmiri SVS, Bassin RH, Gerwin BI, Duran-Troise G. 1976. Phenotypic mixing between N- and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction. Cell 7:373-79
104. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. 2001. The tripartite motif family identifies cell compartments. EMBO J 20:2140-51
105. Roe T, Reynolds TC, Yu G, Brown PO. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-108
106. Rothenberg E, Baltimore D. 1975. Synthesis of long, representative DNA copies of the murine RNA tumor virus genome. J. Virol. 17:168-74
107. Rowe WP, Humphrey JB, Lilly F. 1973. A major genetic locus affecting resistance to infection with murine leukemia viruses. 3. Assignment of the Fv-1 locus to linkage group 8 of the mouse. J. Exp. Med. 137:850-53
108. Scherdin U, Rhodes K, Breindl M. 1990. Transcriptionally active genome regions are preferred targets for retrovirus integration. J. Virol. 64:907-12
109. Schmidtmayerova H, Alfano M, Nuovo G, Bukrinsky M. 1998. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 72:4633-42
110. Schmitz C, Marchant D, Neil SJ, Aubin K, Reuter S, et al. 2004. Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J. Virol. 78:2006-16
111. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-29
112. Schwartz O, Marechal V, Friguet B, Arenzana-Seisdedos F, Heard JM. 1998. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72:3845-50
113. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-50
114. Sheehy AM, Gaddis NC, Malim MH. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1. Vif. Nat. Med. 9:1404-7
115. Shibata R, Kawamura M, Sakai H, Hayami M, Ishimoto A, Adachi A. 1991. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65:3514-20
116. Shibata R, Sakai H, Kawamura M, Tokunaga K, Adachi A. 1995. Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76:2723-30
117. Simon JH, Gaddis NC, Fouchier RA, Malim MH. 1998. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4:1397-400
118. Simon JH, Miller DL, Fouchier RA, Soares MA, Peden KW, Malim MH. 1998. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17:1259-67
119. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-53
120. Tailor CS, Lavillette D, Marin M, Kabat D. 2003. Cell surface receptors for gammaretroviruses. Curr. Top. Microbiol. Immunol. 281:29-106
121. Tang Y, Winkler U, Freed EO, Torrey TA, Kim W, et al. 1999. Cellular motor protein KIF-4 associates with retroviral Gag. J. Virol. 73:10508-13
122. Telesnitsky A, Goff SP. 1997. Reverse transcriptase and the generation of retroviral DNA. In Retroviruses, ed. JM Coffin, SH Hughes, HE Varmus, pp. 121-60. Cold Spring Harbor, NY: Cold Spring Harbor Press
123. Teng B, Burant CF, Davidson NO. 1993. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260:1816-19
124. Towers G, Bock M, Martin S, Takeuchi Y, Stoye JP, Danos O. 2000. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. USA 97:12295-99
125. Towers G, Collins M, Takeuchi Y. 2002. Abrogation of Ref1 retrovirus restriction in human cells. J. Virol. 76:2548-50
126. Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD. 2003. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9:113-43
127. Vajdos FF, Yoo S, Houseweart M, Sundquist WI, Hill CP. 1997. Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci. 6:2297-307
128. Varmus HE, Padgett T, Heasley S, Simon G, Bishop JM. 1977. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11:307-19
129. Weinberg JB, Matthews TJ, Cullen BR, Malim MH. 1991. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174:1477-82
130. Xu L, Yang L, Moitra PK, Hashimoto K, Rallabhandi P, et al. 2003. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp. Cell Res. 288:84-93
131. Yang WK, Yang D-M, Kiggans JOJ. 1980. Synthesis and circularization of N- and B-tropic retroviral DNA in Fv-1 permissive and restrictive mouse cells. Proc. Natl. Acad. Sci. USA 77:2994-98
132. Yap MW, Stoye JP. 2003. Intracellular localisation of Fv1. Virology 307:76-89
133. Yoo S, Myszka DG, Yeh C, McMurray M, Hill CP, Sundquist WI. 1997. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269:780-95
134. Yu X, Yu QC, Lee TH, Essex M. 1992. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J. Virol. 66:5667-70
135. Yuan B, Fassati A, Yueh A, Goff SP. 2002. Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J. Virol. 76:10801-10
136. Yuan B, Li X, Goff SP. 1999. Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:4700-10
137. Yueh A, Goff SP. 2003. Phosphorylated serine residues and an arginine-rich domain of the moloney murine leukemia virus p12 protein are required for early events of viral infection. J. Virol. 77:1820-29
138. Yung E, Sorin M, Pal A, Craig E, Morozov A, et al. 2001. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat. Med. 7:920-26
139. Yung E, Sorin M, Wang EJ, Perumal S, Ott D, Kalpana GV. 2004. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance. J. Virol. 78:2222-31
140. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98
141. Zheng R, Ghirlando R, Lee MS, Mizuuchi K, Krause M, Craigie R. 2000, Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex. Proc. Natl. Acad. Sci. USA 97:8997-9002